RNA medicines can reduce the production of proteins involved in disease by acting on the messages cells use to make them. Their development has produced treatments for inherited nerve disorders, ...
Colorectal cancer in young people shows genetic and structural differences that may make it more aggressive and treatment-resistant than the cancer tends to be in older people.
Nomic Bio Inc., a proteomics company, and Parse Biosciences, a provider of single-cell sequencing and a QIAGEN company, today announced their partnership to generate Cascade, a large-scale multimodal, ...
A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...
The Hyderabad-based drugmaker reported consolidated net profit of Rs 441 crore, up 126 percent from the year-ago period.
Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, along with researchers at ...
Parse Biosciences and Nomic Bio partner on Cascade, a 100 million cell dataset pairing RNA and protein data to speed immune drug target discovery.
3hon MSN
Will Moderna Soar on Nov. 6?
Moderna shares have outperformed tech giants this year.
A new study finds miR-3663-3p is upregulated in chronic kidney disease patients with vascular calcification and promotes ...
First-in-human study evaluates Strand’s ability to unlock the potential of systemic mRNA-encoded medicines with an IL-12 ...
FDA releases CRISPR medicine framework for personalized gene therapies, building on Baby KJ's case. Danaher's Kassim flags ...
ProQR to present its ADAR-mediated RNA editing approach and progress toward next-generation editing oligonucleotides at TIDES ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results